The present invention relates to a method of in vivo imaging with meta-[123I]iodobenzylguanidine ([123I]mIBG) and more particularly wherein said method is used to stratify a defined subset of subjects with heart failure into particular treatment regimens.
申请公布号
WO2016188966(A1)
申请公布日期
2016.12.01
申请号
WO2016EP61609
申请日期
2016.05.23
申请人
GE HEALTHCARE LIMITED
发明人
PROVOST, Jean-Claude Gaston;JONES, Paul Alexander;MONTAGUT, Etienne;CHAHAL, Jay;JOHNSON, Meridith Keating
